酮康唑市场：现况分析与预测（2023-2030）

由于合作伙伴关係和收购的增加，酮康唑市场预计在预测期内将以 3.1% 的复合年增长率强劲增长。 例如，2020 年 9 月，Alliance 与 Alniche 独家合作，在印度销售 Nizral &Nizoral（酮康唑，以 Nizoral 品牌销售）。 其他几个因素也促进了市场的快速扩张，包括产品推出数量的增加、食品和製药行业酮康唑使用量的增加、人口增长、护肤品需求的快速增长、企业合作伙伴关係和产品发射。 例如，2020 年 11 月，山德士与 Civica Rx 合作，向美国医院运送了首款药物泮托拉唑。

依产品类型，市场分为酮康唑口服製剂、酮康唑外用製剂及酮康唑洗髮精。 由于其易于表面应用，外用酮康唑细分市场在 2022 年占据最高市场份额。 本品用于治疗各种类型的真菌性皮肤感染，也可预防復发。 此外，外用製剂的生产更容易、更便宜，使其在市场上更具竞争力。 製造商努力改善其产品的用户体验并使其更易于使用。 因此，酮康唑外用细分市场在 2022 年将占据重要市场份额。

依应用，市场分为抗真菌、除毛等。 由于脱髮病例数量不断增加，预计除毛领域在预测期内将以最高复合年增长率增长。 此外，对护髮药物不断增长的需求、对安全药物替代品的需求、策略联盟和合作研究以及创新产品的推出都进一步推动了对智慧产品的需求。 因此，预计脱毛领域将在预测期内在市场上占据主导地位。

为了更了解酮康唑产业的市场实施情况，将市场分为北美（美国、加拿大、北美其他地区）、欧洲（德国、英国、法国、西班牙、义大利、欧洲其他地区）、亚太地区（中国、日本、印度、亚太地区其他地区）及世界其他国家。 2022年酮康唑市场由北美主导。 尖端和创新产品的可用性、人们对健康问题的认识不断提高以及该地区不断增长的城市人口正在推动对这些抗真菌药物的需求以及对酮康唑产品开发的投资。有几个因素正在推动该地区的市场，包括： 按地区划分，2022 年北美将主导酮康唑市场。

目录

第一章市场介绍

• 市场定义
• 主要目标
• 利害关係人
• 限制

第二章研究方法或假设

• 调查过程
• 调查方法
• 受访者简介

第三章市场总结

第 4 章执行摘要

第五章 COVID-19 对酮康唑市场的影响

第 6 章酮康唑市场收入（2020-2030）

第 7 章按产品类型划分的市场洞察

• 酮康唑口服製剂
• 酮康唑外用製剂
• 酮康唑洗髮精

第 8 章按应用划分的市场洞察

• 抗霉菌剂
• 脱毛
• 其他

第 9 章按地区划分的市场洞察

• 北美
  • 美国
  • 加拿大
  • 北美其他地区
• 欧洲
  • 德国
  • 英国
  • 法国
  • 义大利
  • 西班牙
  • 欧洲其他地区
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 亚太地区其他地区
• 世界其他地区

第10章酮康唑市场动态

• 市场驱动因素
• 市场挑战

第 11 章酮康唑市场机会

第十二章酮康唑市场趋势

第十三章需求方与供给方分析

• 需求方分析
• 供给面分析

第14章价值链分析

第15章竞争场景

• 竞争状况
  • 波特五力分析

第十六章公司简介

• Mylan Inc.
• Almirall, S.A
• Johnson & Johnson Services, Inc.
• Taro Pharmaceutical Industries Ltd.
• Teva Pharmaceutical Industries Ltd.
• Sandoz Group AG
• Strides Pharma Science Limited.
• LGM Pharma
• Agrat Chemicals and Pharmaceuticals
• AKSHAR PHARMA

第十七章免责声明

Ketoconazole is an antifungal medication used to treat various fungal infections like athlete's foot, ringworm, and yeast infections. It's available in different forms like shampoo, cream, and oral tablets. It works by inhibiting the growth of fungi. However, it's essential to use it as prescribed by a healthcare professional due to potential side effects and interactions with other medications. The ketoconazole market is growing at a tremendous rate owing to the higher cases of skin problems. Other factors such as the increased utilization of ketoconazole in the healthcare industry due to the rise in fungal infections, the growing awareness among consumers regarding health concerns, and a rise in the urban population are driving factors for the market.

The Ketoconazole Market is expected to grow at a strong CAGR of 3.1% during the forecast period owing to the rising partnerships and acquisitions. For instance, in September 2020, Alliance exclusively partnered with Alniche to market Nizral & Nizoral (Ketoconazole, sold under the brand name Nizoral) in India. Several other factors such as an increased number of product launches, increased usage of ketoconazole in the food and pharma industry, rising population, upsurge in demand for skincare products, company collaborations, and product launches are also leading to the surge in the market. For instance, in November 2020, Sandoz shipped its first medicine Pantoprazole in collaboration with Civica Rx to supply US hospitals.

Based on product type, the market is segmented into ketoconazole oral, ketoconazole topical, and ketoconazole shampoo. The ketoconazole topical segment held the highest share of the market in the year 2022 owing to the ease of applying it on the surface. It is used to treat skin infections caused by different types of fungus and can also prevent them from coming back. Also, manufacturing topical form is easier and less expensive, which provides competitive pricing to the segment in the market. Manufacturers strive to improve their product's user experience to make it more accessible. Hence, the ketoconazole topical segment held a significant share of the market in the year 2022.

Based on application, the market is segmented into antifungal, hair loss, and others. The hair loss segment is expected to grow with the highest CAGR during the forecast period owing to rising cases of hair loss. Also, the rising demand for haircare medicines, the need for safe options for medicines, strategic collaborations and collaborations, and innovative product launches have further increased the demand for intelligent products. Thus, the hair loss segment is expected to gain prominence in the market in the forecast period.

For a better understanding of the market adoption of the ketoconazole industry, the market is analyzed based on its worldwide presence in countries such as North America (U.S., Canada, and Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. North America dominated the market of ketoconazoles in 2022. Several factors such as the availability of cutting-edge and innovative products, growing awareness about health concerns, the rising urban population in the region are increasing the demand for such antifungal drugs, and loaded investment in ketoconazole product discovery are driving the market in the region. North America dominated the ketoconazole market among regions in the year 2022.

Some of the major players operating in the market include: Mylan Inc.; Almirall, S.A; Johnson & Johnson Services, Inc.; Taro Pharmaceutical Industries Ltd.; Teva Pharmaceutical Industries Ltd.; Sandoz Group AG; Strides Pharma Science Limited; LGM Pharma; AKSHAR PHARMA; Gonane Pharma.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

• 1.1. Market Definitions
• 1.2. Main Objective
• 1.3. Stakeholders
• 1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

• 2.1. Research Process of the Ketoconazole Market
• 2.2. Research Methodology of the Ketoconazole Market
• 2.3. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 IMPACT OF COVID-19 ON THE KETOCONAZOLE MARKET

6 KETOCONAZOLE MARKET REVENUE (USD BN), 2020-2030F

7 MARKET INSIGHTS BY PRODUCT TYPE

• 7.1. Ketoconazole Oral
• 7.2. Ketoconazole Topical
• 7.3. Ketoconazole Shampoo

8 MARKET INSIGHTS BY APPLICATION

• 8.1. Antifungal
• 8.2. Hair Loss
• 8.3. Others

9 MARKET INSIGHTS BY REGION

• 9.1. North America
  • 9.1.1. U.S.
  • 9.1.2. Canada
  • 9.1.3. Rest of North America
• 9.2. Europe
  • 9.2.1. Germany
  • 9.2.2. U.K.
  • 9.2.3. France
  • 9.2.4. Italy
  • 9.2.5. Spain
  • 9.2.6. Rest of Europe
• 9.3. Asia-Pacific
  • 9.3.1. China
  • 9.3.2. Japan
  • 9.3.3. India
  • 9.3.4. Rest of Asia-Pacific
• 9.4. Rest of World

10 KETOCONAZOLE MARKET DYNAMICS

• 10.1. Market Drivers
• 10.2. Market Challenges

11 KETOCONAZOLE MARKET OPPORTUNITIES

12 KETOCONAZOLE MARKET TRENDS

13 DEMAND AND SUPPLY-SIDE ANALYSIS

• 13.1. Demand Side Analysis
• 13.2. Supply Side Analysis

14 VALUE CHAIN ANALYSIS

15 COMPETITIVE SCENARIO

• 15.1. Competitive Landscape
  • 15.1.1. Porters Fiver Forces Analysis

16 COMPANY PROFILED

• 16.1. Mylan Inc.
• 16.2. Almirall, S.A
• 16.3. Johnson & Johnson Services, Inc.
• 16.4. Taro Pharmaceutical Industries Ltd.
• 16.5. Teva Pharmaceutical Industries Ltd.
• 16.6. Sandoz Group AG
• 16.7. Strides Pharma Science Limited.
• 16.8. LGM Pharma
• 16.9. Agrat Chemicals and Pharmaceuticals
• 16.10. AKSHAR PHARMA

17 DISCLAIMER